Can axitinib treat cancer metastasis?

Axitinib is primarily approved for the treatment of advanced renal cell carcinoma, rather than cancer-specific metastases. However, because axitinib is a multi-target inhibitor that inhibits key receptors such as the vascular endothelial growth factor receptor (VEGFR), it has also been studied in some cases to treat other cancers. For the treatment of cancer metastasis, it is usually necessary to comprehensively consider multiple treatment methods, including surgery, radiotherapy, immunotherapy, etc. The use of axitinib may be one of these targeted therapies, and the specific effects may vary depending on individual differences and cancer type. Patients should develop an individualized treatment plan under the guidance of a professional medical team and conduct treatment according to the doctor's recommendations.